Featured Speakers Include MJNA CEO Stuart Titus, Ex-NFL Star Marvin Washington, HempMeds’ CBD Hemp Oil Advocate Penny Howard in Booth 614 & 615 on Feb. 27-28
SAN DIEGO, Feb. 22, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc.’s (OTC Pink:MJNA) HempMeds® is pleased to announce from the Southwest Cannabis Conference and Expo in Fort Worth, Texas, its newest product line with zero tetrahydrocannabinol (THC) content: RSHO-X™, which is now for sale across the U.S.
RSHO-X™ is the U.S.’ newest legal cannabis export that is making global headline news for its role in reversing the public’s perception on “the war on drugs” in countries including Mexico and Brazil. The Company proudly features no-THC and low-THC cannabis CBD hemp oil product lines that are readily available online and ship to all 50 U.S. states, district and territories.
During the two-day conference and expo held at the Fort Worth Convention Center Feb. 27 and 28, Medical Marijuana, Inc.’s Chief Executive Officer, Dr. Stuart W. Titus, will take the stage and discuss:
- The company’s mission of “access for all”
- Medical Marijuana, Inc.’s cannabis industry advances both in the U.S. and around the world
- Introduction of zero-THC content products including RSHO-X™ for “low-THC cannabis states” and all 50 states
- MJNA’s entry into cannabis-based pharmaceutical and drug development
- The Company’s role in creating a new, legal U.S. cannabis export commerce category: CBD hemp oil
Also at the conference, HempMeds® is also proudly announcing two of its newest spokespersons – both of whom are Dallas, Texas, natives and both of whom are featured guest speakers:
Marvin Washington – HempMeds® Sports and Medical Advisor: Washington is a retired NFL player who played a total of 11 years with three teams: the New York Jets, Denver Broncos and San Francisco 49ers. He was a member of the Denver Broncos 1998 Super Bowl-winning team and was voted by Sports Illustrated as the 36th best N.Y. Jet of all-time. Washington has been a featured speaker on cannabis and CBD use in professional sports in and on the Players Tribune, The New York Times, ESPN’s Outside the Lines, Fox News, and more.
Penny Howard – HempMeds® Parent Advocate: Dallas’ outspoken parent advocate of RSHO™ hemp oil use in all 50 states, Penny Howard knows first-hand the profound impact that daily cannabis use had on her daughter, Harper, who bravely battled CDKL5 epilepsy for five years. Harper’s journey, as told by her mother, has been featured in and on: The Huffington Post, CW33, ABC Dallas, Star Local Media, U-T Community Spotlight Radio, and more.Hope4Harper.com played a pivotal role in the legalization of RSHO™ CBD hemp oil in Brazil.
CBD hemp oil products to be featured by HempMeds® at booths 614 & 615 include:
- RSHO-X™: THC-Free Liquid, Gold Oil, Powder
- RSHO™: Low-THC Cannabis Liquid, Decarboxylated Oil, Raw Oil, CO2 Extract Oil, Capsules, Salve
- Dixie Botanicals™: Low-THC Cannabis Oral Applicator, Dew Drops™, Capsules, Salvation Balm
- Cannabis Beauty DEFINED™: Low-THC Cannabis luxury skin care featured by Forbes’ Top 5 Christmas Cannabis Gifts, USA Today and The Huffington Post.
For more information on HempMeds® and their all-natural hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds® through the Company’s social media websites on Facebook and Twitter.
To schedule interviews, photograph and sample some of the world’s most covered CBD hemp oil products at the Southwest Cannabis Conference and Expo, contact Denise Mahaffey, co-Founder of CMW Media at 760.908.6565 or firstname.lastname@example.org.
About Dixie Botanicals
Regarded as one of the most well recognized brands in the industry, Dixie Botanicals™ offers innovative hemp oil products for health conscious consumers. Our formulation experts include scientists, clinical herbalists and nutritionists who work to integrate our hemp oil into a variety of unique products. Dixie Botanicals™ products contain naturally occurring cannabidiol (CBD) hemp oil from the mature stalk of the industrial hemp plant. We test and analyze our products from seed to shelf, ensuring that every natural product we offer is free from contaminants and of the highest quality possible. (Click to view test results.) For more information, visit: www.DixieBotanicals.com.
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visitwww.medicalmarijuanainc.com.
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.